KU Leuven, Belgium
Pascal Borry is assistant professor of bioethics at the Centre for Biomedical Ethics and Law (University of Leuven, Belgium). His research is focused on fundamental and applied research in bioethics. His main research activities are concentrated on the ethical, legal and social implications of genetic and genomics. He published among other issues on topics such as direct to consumer genetic testing, public health genomics, biobanking, research on human tissue, genetic testing, preconceptional screening and neonatal screening. He published as well on the relation between empirical and normative approaches in bioethics. He published more than 100 publications in international peer reviewed journals.
Pascal Borry is involved in various national and international research projects. This includes projects such as GENEBANC (Genetic bio and dataBanking: Confidentiality and protection of data. Towards a European harmonisation and policy), ENGAGE (European network of genomic and genetic epidemiology), EUROGENTEST, Public Health Genomics II, EUCellex (Cell-based regenerative medicine: new challenges for EU legislation and governance), PACITA (Parliaments and civil society in technology assessment), and the Marie Curie project Ethical, legal and Social aspects of direct-to-consumer genetic testing. He is also Vice-chair of the COST ACTION IS1303 Citizen's Health through public-private Initiatives: Public health, Market and Ethical perspectives (CHIP ME).
He is programme director of the Master of Bioethics and teaches medical ethics to medical students. He is member of the Flemish Commission on neonatal screening (2012-2017), member of the Belgian Consultative Committee on Bioethics (2014-2018) and expert of the Superior Health Council (2014-2020). Within the European Society of Human Genetics he is member of the Professional and Public Policy Committee (2009-2016) and elected member of the board (2012-2017). Within the university he is member of the steering group YouReCa (Young Researchers Careers). Recently he became member of the Ethics Committee of the World Anti-Doping Agency.
He received various prizes. In 2006 he received the triennal prize for biomedical ethics ‘Professor Roger Borghgraef’. In 2014 he also received the Innovation Prize of the Dutch Association for Community Genetics and Public Health Genomics, and in 2015 the prize of the Dutch Society for Bioethics. In 2015 he also received the Science Communication Award of the Royal Flemish Academy of Belgium for Science and the Arts. He was a visiting scholar at the Case Western Reserve University, the Université de Montréal, and the VU Medical Center Amsterdam . He is still Invited scholar at the Center for Genomics and Policy of Mc Gill University.